Parcetasal

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C17H15NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3LSZ7869T2, chemically known as acetamide, n-(4-((2-methyl-4-oxo-4h-1,3-benzadioxin-2-yl)oxy)-phenyl)- but generally known as parcetasal, which bears US NIH Compound Identifier 65656. European Medicines Agency schedules Parcetasal in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09621MIG. The term PARCETASAL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 6, No, 3 1992, List 32). PARCETASAL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule parcetasal under HS 29329985 and SITC 51569. As of Q4 2014, PARCETASAL remains the US FDA Preferred Term for this commodity. Parcetasal bears US NLM identifiers UMLS ID C1882287 and NCI Concept Code C66315. SMILES: O1C(OC(=O)C2C1CCCC2)(OC1CCC(NC(=O)C)CC1)C.